# Effects of GLP-1RAs on Reproductive Outcomes in PCOS and Obesity

> **NCT06775093** · NA · NOT_YET_RECRUITING · sponsor: **Peking University Third Hospital** · enrollment: 392 (estimated)

## Conditions studied

- Polycystic Ovary Syndrome
- Obesity
- Infertility, Female

## Interventions

- **DRUG:** GLP-1 receptor agonist
- **DRUG:** Metformin
- **BEHAVIORAL:** healthy lifestyle education

## Key facts

- **NCT ID:** NCT06775093
- **Lead sponsor:** Peking University Third Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-03-01
- **Primary completion:** 2026-12-31
- **Final completion:** 2027-12-31
- **Target enrollment:** 392 (ESTIMATED)
- **Last updated:** 2025-01-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06775093

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06775093, "Effects of GLP-1RAs on Reproductive Outcomes in PCOS and Obesity". Retrieved via AI Analytics 2026-07-01 from https://api.ai-analytics.org/clinical/NCT06775093. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*